Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (KCT0012638) titled 'A randomized, double-blind, crossover, placebo-controlled human study to evaluate the efficacy and safety of IR-2022-002 in alleviating hangovers' on Sept. 17.
Study Type: Interventional Study
Study Design:
Primary Purpose : Other(Hangover cure), Intervention Model : Cross-over, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Dong-A Pharm
Condition:
Not Applicable
Intervention:
Others(Hangover cure) : On the days of the first and second visits, subjects consumed a standard meal at the study site and then, 30 minutes prior to alcohol consumption, ingested ei...